Manufacturers Life Insurance Company, The Ultragenyx Pharmaceutical Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 238,055 shares of RARE stock, worth $10 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
238,055
Previous 247,138
3.68%
Holding current value
$10 Million
Previous $10.2 Million
30.19%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding RARE
# of Institutions
324Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$418 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$236 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$215 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$175 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$129 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.95B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...